JP2004529177A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004529177A5 JP2004529177A5 JP2002589015A JP2002589015A JP2004529177A5 JP 2004529177 A5 JP2004529177 A5 JP 2004529177A5 JP 2002589015 A JP2002589015 A JP 2002589015A JP 2002589015 A JP2002589015 A JP 2002589015A JP 2004529177 A5 JP2004529177 A5 JP 2004529177A5
- Authority
- JP
- Japan
- Prior art keywords
- keto
- composition
- prostaglandin compound
- prostaglandin
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 14
- 125000000217 alkyl group Chemical group 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 125000004043 oxo group Chemical group O=* 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 208000010412 Glaucoma Diseases 0.000 claims 2
- 206010030043 Ocular hypertension Diseases 0.000 claims 2
- 125000001931 aliphatic group Chemical group 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- TVHAZVBUYQMHBC-SNHXEXRGSA-N unoprostone Chemical compound CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O TVHAZVBUYQMHBC-SNHXEXRGSA-N 0.000 claims 2
- -1 13,14-dihydro-15-keto-prostaglandin compound Chemical class 0.000 claims 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000004423 acyloxy group Chemical group 0.000 claims 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 150000001721 carbon Chemical group 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 229940023490 ophthalmic product Drugs 0.000 claims 1
- 229940054534 ophthalmic solution Drugs 0.000 claims 1
- 239000002997 ophthalmic solution Substances 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29035501P | 2001-05-14 | 2001-05-14 | |
| PCT/JP2002/004600 WO2002092098A1 (en) | 2001-05-14 | 2002-05-13 | Method for treating ocular hypertension and glaucoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004529177A JP2004529177A (ja) | 2004-09-24 |
| JP2004529177A5 true JP2004529177A5 (enExample) | 2005-12-22 |
Family
ID=23115609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002589015A Pending JP2004529177A (ja) | 2001-05-14 | 2002-05-13 | 高眼圧症および緑内障の処置方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050014837A1 (enExample) |
| EP (1) | EP1390035A1 (enExample) |
| JP (1) | JP2004529177A (enExample) |
| KR (1) | KR20040008174A (enExample) |
| CN (1) | CN1525861A (enExample) |
| BR (1) | BR0209601A (enExample) |
| CA (1) | CA2444627A1 (enExample) |
| MX (1) | MXPA03010363A (enExample) |
| NO (1) | NO20035043D0 (enExample) |
| WO (1) | WO2002092098A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003082257A2 (en) * | 2002-03-28 | 2003-10-09 | Sucampo Ag | Method for treating ocular hypertension and glaucoma |
| US8580851B2 (en) | 2002-08-21 | 2013-11-12 | Sucampo Ag | Ophthalmic solution |
| AR043161A1 (es) * | 2003-02-14 | 2005-07-20 | Sucampo Pharmaceuticals Inc | Composicion oftalmica para tratar hipertension ocular y glaucoma |
| ES2431640T3 (es) * | 2003-08-21 | 2013-11-27 | Sucampo Ag | Composición oftálmica que comprende éster isopropílico de unoprostona y un agente de viscosidad |
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| US12478503B2 (en) | 2009-05-18 | 2025-11-25 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
| ES2911174T3 (es) | 2010-07-29 | 2022-05-18 | Allergan Inc | Soluciones de bimatoprost y timolol sin conservantes |
| US9061034B2 (en) | 2010-07-29 | 2015-06-23 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5212200A (en) * | 1987-09-18 | 1993-05-18 | R-Tech Ueno, Ltd. | Ocular hypotensive agents |
| US5208256A (en) * | 1990-05-22 | 1993-05-04 | R-Tech Ueno, Ltd. | Treatment of ocular hypertension with a synergistic combination for ocular administration |
| ATE207360T1 (de) * | 1992-03-19 | 2001-11-15 | R Tech Ueno Ltd | Behandlung von augenhochdruck mit betablockern und prostansäurederivaten |
| TW420611B (en) * | 1995-03-10 | 2001-02-01 | R Tech Ueno Ltd | Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder |
| WO2000038689A1 (en) * | 1998-12-25 | 2000-07-06 | Sucampo, A.G. | Drug compositions for the treatment of ocular hypertension or glaucoma |
| US6458836B1 (en) * | 2000-03-16 | 2002-10-01 | Sucampo, A.G. | Treatment of ocular hypertension and glaucoma |
-
2002
- 2002-05-13 KR KR10-2003-7014707A patent/KR20040008174A/ko not_active Withdrawn
- 2002-05-13 CA CA002444627A patent/CA2444627A1/en not_active Abandoned
- 2002-05-13 EP EP02724768A patent/EP1390035A1/en not_active Withdrawn
- 2002-05-13 WO PCT/JP2002/004600 patent/WO2002092098A1/en not_active Ceased
- 2002-05-13 JP JP2002589015A patent/JP2004529177A/ja active Pending
- 2002-05-13 BR BR0209601-3A patent/BR0209601A/pt not_active IP Right Cessation
- 2002-05-13 MX MXPA03010363A patent/MXPA03010363A/es unknown
- 2002-05-13 US US10/477,359 patent/US20050014837A1/en not_active Abandoned
- 2002-05-13 CN CNA028137566A patent/CN1525861A/zh active Pending
-
2003
- 2003-11-13 NO NO20035043A patent/NO20035043D0/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100335049C (zh) | 泻药组合物 | |
| DK2653468T3 (en) | Bicyclic compound AND USE THEREOF FOR MEDICAL PURPOSES | |
| JP2004527567A5 (enExample) | ||
| CA2600331A1 (en) | Use of 11-deoxy-prostaglandin for treating peripheral vascular diseases | |
| RU2002103597A (ru) | Композиция для лечения нарушений внешней секреции | |
| JP2005504836A5 (enExample) | ||
| JP2015521167A (ja) | Ｓｓａｏの置換３−ハロアリルアミン阻害剤およびその使用 | |
| RU2005117964A (ru) | Замещенные 4-алкоксиоксазолпроизводные в качестве агонистов ppar | |
| DE69132713D1 (de) | Benzylidenthiazolidinderivate, ihre Herstellung und ihre Anwendung als Lipidperoxid-Inhibitoren | |
| JP2004507521A5 (enExample) | ||
| JP2006513232A5 (enExample) | ||
| JP2004529177A5 (enExample) | ||
| US9150537B2 (en) | Bicyclic compound and use thereof for medical purposes | |
| CA3145738A1 (en) | Difluorohaloallylamine sulfone derivative inhibitors of lysyl oxidases, methods of preparation, and uses thereof | |
| KR950000663A (ko) | 트리테르펜 유도체 및 이를 함유하는 엔도텔린-수용체 길항물질 | |
| JP2004529960A5 (enExample) | ||
| JP2004519412A5 (enExample) | ||
| JP2009525970A5 (enExample) | ||
| TWI324589B (en) | Halogenated bioactive lipid compound | |
| JP2006506381A5 (enExample) | ||
| JP2004538306A5 (enExample) | ||
| TWI384988B (zh) | 處理中樞神經系統失常用之組成物 | |
| JP2008528440A5 (enExample) | ||
| JP2007518685A5 (enExample) | ||
| JP2004521960A5 (enExample) |